...
首页> 外文期刊>JMIR Research Protocols >The Detroit Young Adult Asthma Project: Proposal for a Multicomponent Technology Intervention for African American Emerging Adults With Asthma
【24h】

The Detroit Young Adult Asthma Project: Proposal for a Multicomponent Technology Intervention for African American Emerging Adults With Asthma

机译:底特律的年轻成人哮喘项目:针对非洲裔美国新兴成年人哮喘的多组分技术干预方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Racial and ethnic minority youth have poorer asthma status than white youth, even after controlling for socioeconomic variables. Proper use of asthma controller medications is critical in reducing asthma mortality and morbidity. The clinical consequences of poor asthma management include increased illness complications, excessive functional morbidity, and fatal asthma attacks. There are significant limitations in research on interventions to improve asthma management in racial minority populations, particularly minority adolescents and young adults, although illness management tends to deteriorate after adolescence during emerging adulthood, the unique developmental period beyond adolescence but before adulthood. Objective The objective of the pilot study was to test the feasibility, acceptability, and signals of efficacy of an intervention targeting adherence to controller medication in African American youth (ages 18-29) with asthma. All elements of the protocol were piloted in a National Heart, Lung, and Blood Institute (NHLBI)–funded pilot study (1R34HL107664 MacDonell). Results suggested feasibility and acceptability of the protocol as well as proof of concept. We are now ready to test the intervention in a larger randomized clinical trial. Methods The proposed study will include 192 African American emerging adults with moderate to severe persistent asthma and low controller medication adherence recruited from clinic, emergency department, and community settings. Half of the sample will be randomized to receive a multicomponent technology-based intervention targeting adherence to daily controller medication. The multicomponent technology-based intervention consists of 2 components: (1) 2 sessions of computer-delivered motivational interviewing targeting medication adherence and (2) individualized text messaging focused on medication adherence between the sessions. Text messages will be individualized based on ecological momentary assessment. The remaining participants will complete a series of computer-delivered asthma education modules matched for length, location, and method of delivery of the intervention session. Control participants will also receive text messages between intervention sessions. Message content will be the same for all control participants and contain general facts about asthma (not tailored). Results It is hypothesized that youth randomized to multicomponent technology-based intervention will show improvements in medication adherence (primary outcome) and asthma control (secondary outcome) compared with comparison condition at all postintervention follow-ups (3, 6, 9, and 12 months). The proposed study was funded by NHLBI from September 1, 2016 through August 31, 2021. Conclusions This project will test a brief, technology-based intervention specifically targeting adherence to asthma controller medications in an under-researched population, African American emerging adults. If successful, our multicomponent technology-based intervention aimed at improving adherence to asthma medications has the potential to improve quality of life of minority emerging adults with asthma at relatively low cost. It could eventually be integrated into clinical settings and practice to reach a large number of emerging adults with asthma. Trial Registration ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT03121157","term_id":"NCT03121157"}} NCT03121157 ; https://clinicaltrials.gov/ct2/show/ {"type":"clinical-trial","attrs":{"text":"NCT03121157","term_id":"NCT03121157"}} NCT03121157 (Archived by WebCite at http://www.webcitation.org/6wq4yWHPv).
机译:背景技术即使控制了社会经济变量,种族和少数民族青年的哮喘状况也比白人青年差。正确使用哮喘控制药物对于降低哮喘死亡率和发病率至关重要。哮喘管理不善的临床后果包括疾病并发症增加,功能性发病率增加和致命的哮喘发作。在改善少数族裔人群,特别是少数族裔青少年和年轻人的哮喘管理的干预措施方面,研究的局限性很大,尽管在成年后,成年后但成年前的独特发展时期,疾病管理趋于恶化。目的这项初步研究的目的是测试针对坚持控制药物治疗的非洲裔美国年轻人(18-29岁)哮喘的干预措施的可行性,可接受性和疗效信号。该方案的所有要素均在美国国家心脏,肺和血液研究所(NHLBI)资助的试验研究(1R34HL107664 MacDonell)中进行了试验。结果表明该协议的可行性和可接受性以及概念证明。现在,我们准备在更大的随机临床试验中测试干预措施。方法拟议的研究将包括从诊所,急诊室和社区中招募的192位中度至重度持续性哮喘和低控制药物依从性的非洲裔美国新兴成年人。一半的样本将被随机分配以接受基于多组分技术的干预,以针对日常控制药物的依从性为目标。基于多组件技术的干预措施包括2个部分:(1)2场针对药物依从性的计算机传递的动机访谈,以及(2)专注于各次药物之间依从性的个性化短信。文本消息将根据生态瞬时评估进行个性化处理。其余的参与者将完成一系列由计算机提供的哮喘教育模块,这些模块与干预时间的长短,位置和传递方法相匹配。控制参与者还将在干预会话之间接收文本消息。所有控件参与者的消息内容都是相同的,并且包含有关哮喘的一般事实(未经定制)。结果假设在所有干预后的随访(3、6、9和12个月)中,随机分组接受基于多组分技术干预的年轻人与对照组相比,药物依从性(主要结局)和哮喘控制(次要结局)均有改善)。这项拟议的研究由NHLBI于2016年9月1日至2021年8月31日资助。结论该项目将测试一项简短的,基于技术的干预措施,专门针对研究不足的人群中的非裔美国新兴成年人,坚持哮喘控制药物的依从性。如果成功,我们旨在改善对哮喘药物依从性的基于多组分技术的干预措施有可能以相对较低的成本改善少数新兴哮喘患者的生活质量。最终可以将其整合到临床环境和实践中,以覆盖大量新兴的哮喘成年人。试用注册ClinicalTrials.gov {“ type”:“ clinical-trial”,“ attrs”:{“ text”:“ NCT03121157”,“ term_id”:“ NCT03121157”}} NCT03121157; https://clinicaltrials.gov/ct2/show/ {“ type”:“ clinical-trial”,“ attrs”:{“ text”:“ NCT03121157”,“ term_id”:“ NCT03121157”}} NCT03121157(由WebCite存档在http://www.webcitation.org/6wq4yWHPv)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号